EP3645034

21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND HUMAN ALBUMIN FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    29.6.2018
  • :
    30.8.2023
  • :
    18736860.0
  • :
    28.6.2038
  • :
    21-DAY DOSING REGIMEN FOR FUSION PROTEINS COMPRISING FACTOR IX AND HUMAN ALBUMIN FOR PROPHYLACTIC TREATMENT OF HEMOPHILIA AND METHODS THEREOF

29.6.2018
30.8.2023
  • :
    CSL Behring Lengnau AG
  • :
    Biotech Innovation Park, 2543 Lengnau BE, CH
  • :
    LI, Yanyan
  • :
    Furlong, PA 18925, US
  • :
    BENSEN-KENNEDY, Debra
  • :
    Phoenixville, PA 19460, US
  • :
    JACOBS, Iris
  • :
    King of Prussia, PA 19406, US
  • :
    VOIGT, Christine
  • :
    Devon, PA 19333, US
  • :
    201762526377 P
  • :
    29.6.2017
  • :
    US
  • :
    EP2018067523
  • :
    29.6.2018
  • :
    A61K 38/48, C12N 9/64